trending Market Intelligence /marketintelligence/en/news-insights/trending/-_j9PLwHJskx1hWRDW0eDA2 content esgSubNav
In This List

Acerus director steps down

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Acerus director steps down

Acerus Pharmaceuticals Corp. said Luc Mainville stepped down from the Canadian pharmaceutical company's board.

Mainville joined the board in 2016, and also served as the company's interim CEO from Oct. 2, 2017, to May 1, 2018, according to S&P Capital IQ data. He was replaced by Edward Gudaitis, a former vice president and general manager of Allergan PLC's Canadian division, as CEO.